ArticleFrontiers in immunology2025
BIDpred: unraveling B cell Immunodominance hierarchical pattern using statistical feature discovery and deep learning prediction.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Knowledge of B cell immunodominance is important for designing vaccines that may elicit effective immune responses. However, the prevalence and characteristics of B cell immunodominance remain poorly understood. In this study, we introduced an immunodominance score through novel data processing methods and identified statistically significant characteristics of B cell immunodominance at the residue and patch levels. Based on these findings, we developed BIDpred, a B cell ImmunoDominance predictor, that learns newly discovered features by leveraging protein language model embeddings and graph attention network to predict the immunodominance scores. BIDpred demonstrates superior performance in predicting immunodominance scores compared to existing methods while maintaining competitive accuracy with state-of-the-art methods for conventional B cell epitope prediction. To the best of our knowledge, this is the first study to systematically analyze and predict B cell immunodominance patterns, marking a significant advancement in vaccine design research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.